Delivery Order SPE2DB22D2007-SPE2DB25FJ5FK
Award Date 9/23/25
Potential Completion Date 10/15/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of LYNPARZA 150 mg tablets in quantities of 60s, with a ceiling value of $10,499.34. This firm fixed-price delivery order, with an ultimate completion date of September 8, 2025, represents a competitive, non-set-aside award to the prime contractor. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,249.67 to supply Lynparza 150 mg tablets (60-count units) under a firm fixed-price contract. The delivery order, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a non-set-aside, competitively awarded procurement. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen Drug Corp's corporate headquarters and primary...
- The Defense Logistics Agency awarded a $42,270.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Lynparza 150 mg tablets (120-count units) on August 12, 2025, with an ultimate completion date of September 3, 2025. This non-competitive delivery order is being fulfilled from AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of LYNPARZA 150 mg tablets in quantities of 60 units. This contract, valued at $10,499.34, represents a firm fixed-price delivery order with an ultimate completion date of September 22, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order through its...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $31,702.80 on June 16, 2025, for the supply of Lynparza 150 mg tablets (120-count units). This firm fixed-price, competitively awarded contract has a completion date of July 9, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified pharmaceutical distributors. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of LYNPARZA 150 mg tablets (60-count unit dose) with a ceiling value of $10,499.34. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 19, 2025. This delivery order is issued...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of LYNPARZA 150 mg tablets in quantities of 60 units. This delivery order, valued at $10,499.34 under a firm fixed-price contract type, represents a non-competitive procurement and is scheduled for completion by October 7, 2025. The award was issued to AmerisourceBergen's Corporate Office division, with performance occurring at the company's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Lynparza 150 mg tablets (120-count units) valued at $10,567.60, with completion expected by July 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $42,270.40 for Lynparza 150 mg tablets (120-count units) on September 22, 2025, with an ultimate completion date of October 14, 2025. This firm fixed-price, non-competitive set-aside contract is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 through December...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of LYNPARZA 150 mg tablets (60-count units) valued at $5,249.67. This competitively awarded, non-set-aside contract carries a firm fixed price and is scheduled for completion by July 17, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is issued under AmerisourceBergen's...